NCPI Workmark
Articles in regional publications that pertain to a wide range of North Carolina-related topics.

Biomarkers And Early Diagnosis Keys To Lung Cancer Treatment

Record #:
16587
Author(s):
Abstract:
Did you know that in 2010 more than 157,000 Americans died of lung cancer, or that the number of people dying from the disease is increasing? Lung cancer is the deadliest form of cancer, killing more people than the combined total of breast, prostate, colon and pancreatic cancers. In 2009, lung cancer killed 17,500 people in North Carolina -- more than heart disease -- in a state where smoking and diet remain tremendous challenges. Providing a unique overview of the fight against lung cancer is Christopher Ung, vice president of Oncology Thera­peutic Strategy at Research Triangle Park-based Quintiles, the world's largest life sciences testing and services firm. Quintiles works with companies worldwide in medical research, conducting many of the clinical trials companies rely on to test and develop new products. His area of focus is personalized medicine based on biomarkers -- genetic data that could indicate an individual's chances of developing cancer.
Source:
Metro Magazine (NoCar F 264 R1 M48), Vol. 12 Issue 3, May 2011, p28-32, il